Karl Stangl

Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial

Friedrich Koehler, Kerstin Koehler, Oliver Deckwart et al. · The Lancet · 2018 · 740 citations · Full text

Medicine, Cardiology, Clinical Cardiology +9

A Constituent of Green Tea, Epigallocatechin-3-gallate, Activates Endothelial Nitric Oxide Synthase by a Phosphatidylinositol-3-OH-kinase-, cAMP-dependent Protein Kinase-, and Akt-dependent Pathway and Leads to Endothelial-dependent Vasorelaxation

Mario Lorenz, Elena Follmann, Wanda Michaelis et al. · Journal of Biological Chemistry · 2004 · 332 citations · Full text

Veterinary Medicine, Biochemistry, Pharmacology +15

The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells

Antje Ludwig, Mario Lorenz, Nicole Grimbo et al. · Biochemical and Biophysical Research Communications · 2004 · 196 citations

Life Sciences, Cell Biology, Pharmacology +14

HnRNP L stimulates splicing of the eNOS gene by binding to variable-length CA repeats

Jingyi Hui, Karl Stangl, William S. Lane et al. · Nature Structural Biology · 2002 · 168 citations

Life Sciences, Genetics, Molecular Biology +11

Long‐term up‐regulation of eNOS and improvement of endothelial function by inhibition of the ubiquitin–proteasome pathway

Verena Stangl, Mario Lorenz, Silke Meiners et al. · The FASEB Journal · 2004 · 122 citations

Life Sciences, Biochemistry, Cardiology +14